Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Chaim Lebovits currently holds 1,164,865 shares of BRAINSTORM CELL THERAPEUTICS INC. (BCLI), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Chaim Lebovits has been a net buyer of BCLI stock. They have purchased $273.4K and sold $0 worth of shares.
Chaim Lebovits's most recent insider trade was on May 28, 2024, when they purchased 15,000 shares at $0.52 per share.
Chaim Lebovits serves as Executive at BRAINSTORM CELL THERAPEUTICS INC. (BCLI). They have executed 31 insider transactions totaling $273.4K over their tenure at the company.
Chaim Lebovits holds the position of Executive at BRAINSTORM CELL THERAPEUTICS INC., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 9 years and currently hold a stake valued at $0.
Chaim Lebovits has shown a buying trading pattern, with $273.4K in total purchases and $0 in total sales across all transactions. Their most recent activity indicates a tendency to accumulate shares.
The largest transaction by Chaim Lebovits was on Apr 17, 2024, when they purchased $71.5K worth of BCLI shares. This transaction involved 130,000 shares at $0.55 per share.
Chaim Lebovits currently owns 1,164,865 shares of BRAINSTORM CELL THERAPEUTICS INC. (BCLI), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Chaim Lebovits's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Chaim Lebovits has 31 Form 4 filings on record as an insider at BRAINSTORM CELL THERAPEUTICS INC..
Set alerts for Chaim Lebovits and 40,000+ other insiders.